SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-007447
Filing Date
2022-11-09
Accepted
2022-11-09 16:30:40
Documents
48
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_i10q-093022.htm   iXBRL 10-Q 657668
2 CERTIFICATION xenetic_ex3101.htm EX-31.1 10297
3 CERTIFICATION xenetic_ex3102.htm EX-31.2 10378
4 CERTIFICATION xenetic_ex3201.htm EX-32.1 4439
  Complete submission text file 0001683168-22-007447.txt   2781893

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE xbio-20220930.xsd EX-101.SCH 23576
6 XBRL CALCULATION FILE xbio-20220930_cal.xml EX-101.CAL 29849
7 XBRL DEFINITION FILE xbio-20220930_def.xml EX-101.DEF 117700
8 XBRL LABEL FILE xbio-20220930_lab.xml EX-101.LAB 186277
9 XBRL PRESENTATION FILE xbio-20220930_pre.xml EX-101.PRE 153369
42 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10q-093022_htm.xml XML 296198
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 221373148
SIC: 2834 Pharmaceutical Preparations